Levi & Korsinsky Expands Securities Class Action Targets to Healthcare Tech Beyond Biotech

A significant volume spike in events, coinciding with Phio Pharmaceuticals' upcoming presentation at the Global Markets Virtual Forum, indicates heightened activity and scrutiny within the biotech sector. This aligns with a broader trend of increased legal focus on pharmaceutical companies, as evidenced by Levi & Korsinsky's expanded legal actions targeting firms like Sun Pharmaceuticals. The convergence of these events suggests a potentially elevated risk environment for biotech companies, especially those with investor-facing events and those involved in novel therapies.

Sentinel

Participants (12)

Recent events (5)

• Phio Pharmaceuticals to Present at The Global Markets Virtual Forum October 8, 2026

  Oct 06, 2026 LEADER Tone: 0.0 Source
  NasdaqNewsfile CorpSun Pharmaceuticals OnReuters Global Markets ForumAlderman Robert Bauman

• Pluri (NASDAQ:PLUR) and Cytokinetics (NASDAQ:CYTK) Head to Head Comparison

  Oct 04, 2026 TAX_DISEASE_CARDIOMYOPATHY Tone: 0.4 Source
  Pluri IncSun Pharmaceuticals OnPerfuse Therapeutics Team

• Recover Investment Losses: Class Action Initiated Against ARS Pharmaceuticals, ...

  Oct 04, 2026 ECON_WORLDCURRENCIES_DOLLARS Tone: -3.4 Source
  Levi KorsinskyNasdaqSecurities Class Action ServicesUnited States SenateAnime News NetworkSun Pharmaceuticals On

• Join Class Action to Recover Losses from Doximity, Inc. (DOCS) – Contact ...

  Oct 04, 2026 LEGISLATION Tone: -1.6 Source
  Securities Class Action ServicesUnited States SenateAnime News NetworkLevi KorsinskyNeedham Company

• Securities Lawsuit Alert: HDFC Bank Limited (HDB) Investors – Contact ...

  Oct 04, 2026 TAX_FNCACT_EMPLOYEES Tone: -3.8 Source
  Securities Class Action ServicesUnited States SenateAnime News NetworkRepublic Bank LimitedLevi KorsinskyAction Limited V Apple